Low-dose aspirin to reduce recurrence rate in colorectal cancer patients with PI3K pathway alterations: 3-year results from a randomized placebo-controlled trial.

被引：0
|
作者：
Martling, Anna
Lindberg, Johan
Myrberg, Ida Hed
Nilbert, Mef
Mayrhofer, Markus
Gronberg, Henrik
Glimelius, Bengt
ALASCCA Trial Study Grp
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Lund Univ, Lund, Sweden
[3] Akadem Univ Hosp, Uppsala, Sweden
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
基金：
瑞典研究理事会;
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.LBA125
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：LBA125 / LBA125
页数：1
相关论文
共 50 条
  • [31] EFFECTIVE ONCE-DAILY TREATMENT OF HYPERTENSION WITH LOW-DOSE, CONTROLLED-RELEASE METOPROLOL - POOLED RESULTS FROM 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES
    WESTERGREN, G
    OLOFSSON, B
    PARLEVLIET, K
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1994, 55 (02): : 142 - 148
  • [32] The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients
    Marilena Petrera
    Laura Paleari
    Matteo Clavarezza
    Matteo Puntoni
    Silvia Caviglia
    Irene Maria Briata
    Massimo Oppezzi
    Eva Mihajlovic Mislej
    Borut Stabuc
    Michael Gnant
    Thomas Bachleitner-Hofmann
    Wilfried Roth
    Dominique Scherer
    Walter-E. Haefeli
    Cornelia M. Ulrich
    Andrea DeCensi
    BMC Cancer, 18
  • [33] One-year results of golimumab compared with placebo in patients with active RA despite treatment with methotrexate: A phase II, randomized, double-blind, placebo-controlled, dose-ranging trial.
    Kay, J.
    Matteson, E. L.
    Dasgupta, B.
    Nash, P.
    Durez, P.
    Hall, S.
    Hsia, E. C.
    Chiruvolu, P.
    Han, J.
    Rahman, M. U.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S833 - S833
  • [34] Increased PI3K pathway activity is associated with recurrent breast cancer in patients with low and intermediate 21-gene recurrence score
    Lin, Lawrence Hsu
    Wesseling-Rozendaal, Yvonne
    Vasudevaraja, Varshini
    Shen, Guomiao
    Black, Margaret
    van Strijp, Dianne
    Neerken, Sigi
    van de Wiel, Paul A.
    Jour, George
    Cotzia, Paolo
    Darvishian, Farbod
    Snuderl, Matija
    JOURNAL OF CLINICAL PATHOLOGY, 2024,
  • [35] Safety of low-dose aspirin (ASA) in a pooled analysis of 3 randomized, controlled trials (RCTs) of bevacizumab (BV) with chemotherapy (CT) in patients (pts) with metastatic colorectal cancer (mCRC).
    Hambleton, J
    Skillings, J
    Kabbinavar, F
    Bergsland, E
    Holmgren, E
    Holden, SN
    Hurwitz, H
    Scappaticci, F
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 259S - 259S
  • [36] Efficacy and safety of low-dose interleukin-2 in combination with methotrexate in patients with active rheumatoid arthritis: clinical results from the randomized, double-blind, placebo-controlled trial
    Zhang, X.
    He, J.
    Zhang, R.
    Liu, X.
    Chen, J.
    Sun, X.
    Li, Z.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1852 - 1853
  • [37] Pharmacokinetics and Pharmacodynamics of Tocilizumab in Combination with Prednisone Tapering in Patients with Giant Cell Arteritis: 3-Year Results from a Randomized Controlled Phase 3 Trial
    Mallalieu, Navita
    Bao, Min
    Stone, John
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [38] The efficacy and safety of abatacept or infliximab in RA patients with an inadequate response to MTX: Results from a 1-year double-blind, randomized, placebo-controlled trial.
    Schiff, M.
    Keiserman, M.
    Codding, C.
    Songcharoen, S.
    Berman, A.
    Nayiager, S.
    Saldate, S.
    Aranda, R.
    Becker, J-C
    Lin, C.
    Cornet, L. N.
    Dougados, M.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (12): : 4117 - 4118
  • [39] Low daily dose of 3 mg monacolin K from RYR reduces the concentration of LDL-C in a randomized, placebo-controlled intervention
    Heinz, Tina
    Schuchardt, Jan Philipp
    Moeller, Katharina
    Hadji, Peyman
    Hahn, Andreas
    NUTRITION RESEARCH, 2016, 36 (10) : 1162 - 1170
  • [40] Safety of the omega-3 fatty acid, eicosapentaenoic acid (EPA) in psychiatric patients: Results from a randomized, placebo-controlled trial
    Emsley, Robin
    Niehaus, Dana J. H.
    Oosthuizen, Petrus P.
    Koen, Liez
    Ascott-Evans, Brynne
    Chiliza, Bonginkosi
    van Rensburg, Susan J.
    Smit, Retha M.
    PSYCHIATRY RESEARCH, 2008, 161 (03) : 284 - 291
12345